This is a past event. Registration is closed. View other FORTUNE China events.
VIVIAN BIAN
CEO, ROCHE PHARMACEUTICALS CHINAVivian Bian is appointed as Chief Executive Officer of Roche Pharma China on October 1, 2021, responsible for leading its pharmaceutical business in China with a wide range of products in key areas including oncology, rare diseases, and transplantation. Roche is one of the first global pharmaceutical companies that have established a full value chain from Research and Development to Manufacturing, Marketing and Sales in China.
Vivian joined Roche in April 2019 as Head of Market Access for Pharma China. She has advocated for a more favorable and sustainable access environment to enable broader access for Chinese patients to Roche innovation. She has forged flagship strategic partnerships with the healthcare ecosystem stakeholders under Roche China Strategy to improve the healthcare efficiency and patient outcomes.
Vivian holds an MBA degree from the University of Michigan and a Master’s degree in Molecular Biology from the Chinese Academy of Sciences. Prior to joining Roche, she took a number of senior leadership roles at BeiGene and Johnson & Johnson, with rich experiences and expertise in medical affairs, marketing and sales, business operation, market access, and team management.
MAGGIE CHEN
GREATER CHINA MANAGING DIRECTOR, LVMH-SEPHORAMaggie is an experienced Management Executive with demonstrated record of succesfful transformational changes for multinational corporations such as Sephora, Unilever, Blueair, Reckitt Benckiser and Johnson & Johnson. She has been leading business growth for both International and China markets. In November 2018, Maggie joined Sephora China and assigned as Sephora Greater China Managing Director since 2020.
Outside of work, Maggie enjoys art & music, support charity, education & connect senior women executives across industries. She supports diversity and inclusivity. Awarded “Next Generation Leader” on 2013 Europe ECR Conference in Brussels.
NICOLE CHEN
MANAGING DIRECTOR, DATA & ANALYTICS, GREATER CHINA AND NORTH ASIA AT LSEGNicole is the Managing Director, Data & Analytics, Greater China and North Asia at London Stock Exchange Group, with over 20 years of experience in corporate strategy, business development and sales management in the financial services and information technology sectors. Leading the data and analytics business of the London Stock Exchange Group in China, Nicole focuses on the provision of industry data and solutions services for the China market. Nicole has been responsible for the restructuring and transformation of the company over the past 15 years and advocates for the localization of the firm as well as strengthening its leadership in the area of providing data, analysis and insights that are helping to transform China's financial markets in the post-pandemic era. Based on her deep understanding of the digital economy, green economy, financial supply chain, and sustainable investments, she has developed a blueprint for data-enabled innovation for a data platform that connects China's financial markets with the global markets all over the world.
SELENA CHU
VICE PRESIDENT, DOW GREATER CHINASelena Chu is currently the Vice President for Dow Greater China. She provides leadership and general management of Greater China, Dow’s largest international market - oversight of country strategy, sites management, and people & culture development. Based in Shanghai, China, she also serves as CIO for Dow Asia Pacific to drive digital solution development and implementation, covering areas of Digital Acceleration, Enterprise Service, and Information Security. She also partners with businesses and functions to enable regional business strategies.
Selena has over 20 years of consulting and industry experience covering various leadership roles including R&D Operation, Business/Innovation Strategy, Technical Information Service, and Digitization. Prior to joining Dow in 2008, she worked for GE (General Electric), KPMG Consulting Co, with working assignment in the US.
Selena was listed as “Top 50 Women in Tech 2021” by Forbes China, and “Top 50 Future MPW” for both 2021 and 2022 by Fortune China.
JASMINE CUI
CO-FOUNDER, CHAIRWOMAN & CEO, INNOCARE PHARMADr. Jasmine Cui is the Co-founder, Chairwoman & CEO of InnoCare Pharma. InnoCare is a biopharmaceutical company rooted in China with the global vision to discover and develop novel treatment for cancer and autoimmune diseases. Dr. Cui has over 25 years of drug research & development experience.
Prior to founding InnoCare, Dr. Cui was the General Manager of BioDuro (2011-2015), responsible for BioDuro’s overall scientific and operational management, as well as business & resource management. Before BioDuro, Dr. Cui worked at Merck Research Laboratories for 14 years serving as the Chair of Early Development Team for development of drug candidates from preclinical to phase IIa.
Dr. Cui received her Ph.D. in molecular biology from Purdue University and completed her postdoctoral fellowship at Howard Hughes Medical Institute affiliated with the University of Michigan. Dr. Cui was the 17th SAPA President and the first female president for SAPA. She was among 2020 Fortune China Most Powerful Women list.
LI CUI
CHIEF DEVELOPMENT OFFICER AND CHIEF OF STAFF, ZTEMs. Cui Li joined ZTE in 1999. She currently serves as Chief Development Officer and Chief of Staff , focusing on strategic business expansion, and the exploration and development of industry insights. Ms. Cui has extensive work experience in ICT technologies and markets. She has been working as Vice President of ZTE Corporation since 2005, successively in charge of the global strategic planning and marketing of CDMA products and wireless networks, integrated commercial and
technical solutions, and corporate branding.
Ms. Cui has a wealth of technical expertise and managerial experience in the global telecom industry. She is named to the 2021 Forbes China 50 Top Women in Tech and 2021 and 2022 Fortune China's Most Powerful Women in Business - Future List. Ms. Cui Li holds a master's degree in engineering from Southeast University and an EMBA degree from Tsinghua University.
TAMMY TANG
MANAGING DIRECTOR OF CHINA, COLLIERSTammy has over 23 years' experience in the China real estate market, working in both developers, occupiers and brokerage sides. She has worked in Guangzhou, Shanghai, Beijing, Shenyang, Chengdu and Xi'an. Her expertise includes site selection, acquisition, disposition and portfolio strategy for occupiers, as well as development consulting, portfolio strategy, investment, project lease and sales for developers and investors. Because of her diverse experience in the industry, she has indepth knowledge in real estate policy and market dynamics in the China market, providing real insight and value to her clients.
Tammy started her career in residential and retail brokerage. Then start focusing on Industrial properties since 2006. In 2017, she was responsible for Colliers' West China business, covering Chengdu, Xi'an and Chongqing. In 2019, Tammy was promoted as the Managing Director of China for Colliers, responsible for the full scope of businesses all over China.
Tammy focus on leading the growth of Colliers China as the leader in the industry. She continues to attract the best talents. Colliers China is awarded by HR Asia as the Best Company to work for in 3 consecutive years. She leads change by innovation by starting Culture and Leisure Operations services in 2020 while the China focuses on the growth of domestic consumption.
At a personal level, Tammy act as an advisor to mayors and authorities on city development, economic development and investment promotions. She is also active in training young talents in the real estate industry, helping the growth of the industry as a whole.
段妍
《财富》（中文版）MPW项目负责人段妍是财富（中文版）MPW项目负责人。在加入《财富》之前，她曾任职于英国金融时报旗下研究机构，负责消费和消费互联网行业的研究业务，带领团队撰写研究报告，为海外投资机构，跨国企业和国际机构提供咨询服务。 更早之前，她曾就职于中国日报，湖南卫视等多家媒体，担任记者和编导职务。段妍毕业于美国哥伦比亚大学国际关系学院。
XIAOHUI GUAN
EXECUTIVE DIRECTOR & VICE CHAIRMAN, SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTDMs. Guan Xiaohui has extensive experience in operations and financial management, corporate mergers and acquisitions, and capital market operations. She participated in and led a number of investment and financing projects of Fosun Pharma, supported and promoted the company's implementation of innovation and internationalization strategies, and provided key decision-making and support for the company's innovation transformation. At the same time, she led the optimization and upgrading of the financial management system of Fosun Pharma Group, and made outstanding achievements in improving the company's digital management level and promoting ESG management. In recognition of its outstanding performance in ESG, Fosun Pharma topped the top 40 of the first Fortune China ESG Impact List in August 2022. In October 2022, Fosun Pharma’s MSCI ESG rating was further upgraded from BBB to A, ranking the top level in the domestic industry.
MANYING LAI
SENIOR PARTNER, YINGKE PEMs. Lai Manying is the co-founder and current senior partner of Yingke PE, and an EMBA at Guanghua School of Management, Peking University. Adhering to value investing, she led the investment in a large number of high-quality projects such as Yongyue Science&Technology, Earth-Panda Advanced Magnetic Material, Fujian Wanrun New Energy Technology, Kanghua Biological Group from a forward-looking perspective.
Ms. Lai Manying has more than ten years of experience in corporate governance, venture capital, enterprise listing, etc. She has led the team in making continuous value discovery and industrial investment with a strategic vision and a pioneering spirit. Under her management, Yingke PE has become one of the top five domestic venture capital institutions, with an AUM of more than RMB 60 billion. Yingke PE has invested in nearly 300 biomedical and high-tech enterprises and has built an industrial ecosystem with a high degree of synergy.
With her professional investment skills and charming personality, Ms. Lai Manying has won the honors of "Outstanding Innovative Person in China's Equity Investment of the Year", "S50 Chinese Female Investor", "Best Female Investor of the Year", and "Best Young Investor in China's Equity Investment Industry of the Year".
HOLLY LEI
SENIOR VICE PRESIDENT, COVESTRO GROUP; PRESIDENT, COVESTRO CHINAHolly Lei (Senior Vice President, Covestro Group, President of Covestro China) is the first local female leader for this position in Covestro China.
Lei started her career at Bayer MaterialScience (the predecessor company of Covestro) in 1999 as a technical representative, and has since increased responsibilities focusing on sales, marketing and R&D . She held various management positions in China, the APAC region and globally, and devoted her cross-industry insights and customer centric mindset to develop Covestro’s business globally.
As a seasoned leader strong at managing dispersed teams, Lei is also an affectionate people leader and excels at fostering an environment that allows people to flourish and develop to their fullest potential. As an avid ambassador of diversity, equity and inclusion (DEI) at Covestro, she is actively involved in promoting Female leadership in the workplace and DEI culture with outstanding contribution and social influence.
Lei holds a bachelor’s degree in chemical engineering from Dalian University of Technology in China and a master’s degree in material science from Université de Sherbrooke in Canada. She has also received executive training at INSEAD Business School in France.
Lei is also a supervisory board member of GEA Group AG, Vice Chair of the Shanghai Chapter of the European Union Chamber of Commerce in China, and she was granted with several awards, such as 2020 China Women in Tech by Forbes, 2021 China Most Powerful Women by Fortune, etc.
MENGMENG LIANG
FOUNDER AND COO, CIPHER GENEWith 15 years of experience in translational medicine, dedicated to exploring the molecular pathogenic mechanism of disease occurrence and development, preclinical evaluation of new drugs, drug resistance mechanism research and other projects, led the development of a series of clinical genetic diagnosis products based on high-throughput sequencing for Chinese genetic diseases, and successfully launched the first epilepsy diagnosis clinical service based on whole exon sequencing in China. Led the establishment of the first high-throughput platform for clinical function verification and drug research and development services based on zebrafish technology.
Published more than 10 papers in top international journals such as CANCER RESEARCH.
2021 Forbes TOP50 Women in Technology in China, 2021 Most Powerful Women in Business in China by Fortune magazine, 2022 Most Noteworthy Women in Business Leaders by Chuangyebang, etc.
LANXIANG LIU
SENIOR EDITOR OF NEW MEDIA, FORTUNE CHINASince joining the editorial team of fortune China in June 2021, Lanxiang Liu has been mainly responsible for in-depth reports and comments in the field of big finance and real estate. At the same time, she has developed external KOL and participated in the daily operation of the platform in combination with the needs of fortune new media platform. Previously, she worked in institutions such as JD technology, 21st Century Business Herald and Reuters, and established Zhixin Asset Management Research Institute as a co-founder. In 2007, she graduated from the school of Journalism and communication of Peking University, and in 2005, she graduated from the English Department of Beijing International Studies University.
LAN LUO
CO-FOUNDER AND EXECUTIVE DIRECTOR, SHANGHAI XFORCEPLUS TECHNOLOGY CO., LTDLan Luo is the co-founder and executive director of Shanghai Xforceplus Technology Co., Ltd. She has obtained an EMBA degree from Booth Business School of the University of Chicago and a bachelor's degree of computing from the University of Minnesota System.Lan has been committed to promoting the high-quality development of enterprises, customers and the industry from the aspects of business model innovation, international perspective development, and social value contribution. Meanwhile，as the vice president of Shanghai Federation of Returned Overseas Chinese Youth Association and Vice President of Shanghai Overseas Economics and Technology Promotion Association，she actively participates in and promotes business, cultural and talent exchanges between China and other countries, contributing her wisdom and strength to the opening and cooperation in the economic and financial fields between China and other countries, as well as global business innovation.
Before joining Xforceplus, Lan once served as the partner of Ivy Capital and Singularity Capital, as well as an executive of well-known enterprises such as Motorola, PWC(PRTM) and Hanwha Group. She has more than 10 years of experience in Fortune 500 companies and the management consulting industry., and led and participated in numerous investment and equity projects in the fields of technology finance, intelligent manufacturing, and new energy, and successfully completed a number of cross-border mergers and acquisitions between the Chinese and American markets.
Claire Zillman
SENIOR EDITOR, FORTUNE at 《财富》（FORTUNE)Claire Zillman is a Hong Kong-based senior editor for Fortune, where she oversees a team of reporters that covers business in Asia. She also writes stories on women in business and gender in the workplace. Her feature on the then-unbroken glass ceiling at Wall Street’s banking giants won a New York Press Award for business reporting. She co-authors Fortune’s Broadsheet newsletter about women in business and co-chairs various Most Powerful Women conferences. Before moving to Hong Kong in 2020, she worked for Fortune in London and New York. Earlier in her career, Claire was a reporter for The American Lawyer magazine, covering legal affairs. She graduated with degrees in journalism and history from Syracuse University and is originally from Chicago.
CATHY QIAN
VICE PRESIDENT & MARKET ACCESS LEAD, PFIZER GLOBAL BIOPHARMACEUTICALS BUSINESS CHINAMs. Cathy QIAN has more than 25 years of professional experience in market access and public affairs for multinational pharmaceutical companies. Now she is the Vice President and Market Access Lead of Pfizer Global Biopharma Business China, and is responsible for the overall market access strategy and operations management in China. Over the years, Ms. Cathy QIAN has been committed to improving the accessibility and affordability of high-quality innovative drugs in China, actively responding to national policy directions, advocating continuous optimization of the access environment, promoting innovative drugs to benefit more patients through national reimbursement drug list negotiation, early access in pilot zone, and establishing cross-border strategic cooperation, exploring innovative access models such as multi-party co-payment, to enable global pharmaceutical innovation outcomes to land in China. Prior to joining Pfizer, Ms. Cathy QIAN worked for Sanofi, Xi'an Janssen and Roche, and led the market access and public affairs teams in Hong Kong, Macao and Taiwan as Vice President of Public Affairs and Market Access in Greater China. Ms. Cathy QIAN also plays an influential role in several industry associations.
SHARON SHEN
MANAGING DIRECTOR, TPG CAPITAL ASIASharon Shen serves as a Managing Director at TPG Capital Asia, based in Hong Kong. Prior to joining TPG in 2018, Sharon served as a Senior Director with Alvarez & Marsal (A&M). Sharon holds a BBA (Hons) from the Chinese University of Hong Kong, and is also a FRM and CFA charter holder. Sharon currently serves on the Board of several TPG portfolio companies, including Duxiaoman, APM Monaco and CD Finance.
司秀芬
联合创始人兼董事长 at 苏州艾吉威机器人有限公司司秀芬，中南大学工学博士，上海交通大学安泰EMBA、苏州科技领军人才、金鸡湖双百人才。现任苏州艾吉威机器人有限公司董事长，同时担任苏州机器人产业协会理事长、青岛机器人产业协会理事长。所属产业数字工厂智能制造，研究领域包括室内无人驾驶、人工智能、数字孪生、工业物联等技术。
在艾吉威机器人任职期间，率领公司研发出多项行业核心技术，申请专利及软件著作等150余项，覆盖移动搬运机器人导航、定位、调度、运动控制等全领域。参与研发的“无反射板激光导航叉车式AGV”获得2018年度江苏省机械工业科技进步奖一等奖、 江苏省机械专利金奖、2019年度中国机械工业科学技术三等奖。
此外，基于移动搬运机器人AGV及新一代AI技术，开创性地探索出AGV多元化的应用场景，如：石化行业AGV从室内到向室外的落地应用；无人叉车1.6m狭窄货架之间高仓储率转运；立体仓库无人叉车9m高位精准堆码取放;无人叉车自动装卸等细分场景，深入客户需求，帮助实现全流程智能、全数据链通的数字化生产。
SANDY SUN
SENIOR VICE PRESIDENT AND GENERAL MANAGER FOR CHINA REGION, SEAGATESandy Sun currently heads up Seagate’s China Organization and she is responsible for driving the financial performance and success of the group by growing revenue and market share across all of Seagate market segments. Sandy bases in Beijing, in addition to developing new market segments and new revenue streams, she will also oversee all functions relating to sales, marketing and technical support to ensure best-in-class customer service.
Sandy brings with her more than 20 years of working experience in the IT industry with specific strengths in server, storage, network, and software and strong capabilities in sales, marketing, product management, channel and business management.
Sandy joined Seagate in Jan. 2013. Prior to joining Seagate, Sandy has worked in a number of senior positions at IBM including the divisions responsible for PCs, China E-commerce and the China Sales Operation and served as the general manager of IBM System X division in the Greater China since 2004.
Sandy ranks:
The Most Powerful Women of Tomorrow from Fortune China in November. 2022
53rd on the list of Forbes China Outstanding Business Women in March, 2022.
65th on the list of Forbes China Outstanding Business Women in February, 2021.
61st on the list of Forbes China Top Businesswomen in February, 2020.
2020 Forbes China 50 Top Women in Tech.
Sandy Sun is the President of Shenzhen Smart City Association and the member of Shanghai Informatization Committee of Experts.
Sandy holds executive master’s degree of business administration from CKGSB and bachelor’s degree in computer science from Peking University of Technology. She has children of three and lives in Beijing.
SIYI SUN
CHIEF EXECUTIVE OFFICER AND GENERAL MANAGER, SINO-US UNITED METLIFE INSURANCE COMPANYSiyi Sun is Senior Vice President of MetLife Inc, and is appointed CEO/General Manager of Sino-US United MetLife Insurance Company (“MetLife China”) since November 2017.
During Ms. Sun’s tenure, MetLife China ensured sound risk management, focused on customer centricity, and, through innovation and differentiation, provided comprehensive solutions and better experience for customers to satisfy their changing needs. Ms. Sun is committed to promoting gender equality and inclusion in the business environment. She sets clear standards for the "Diversity, Equity, Inclusion" (DEI) culture that is incorporated into the annual goals of all management teams. She also serves as chairperson of the MetLife Asia Pacific DEI Committee.
Ms. Sun has over 20 years of experience in the life insurance industry with a focus on international business. Ms. Sun joined MetLife from ALICO, where she started in 1999. She has held a variety of actuarial and risk management roles at both ALICO and MetLife, including appointed Actuary for ALICO; International Head of Asset and Liability Management for Asia and EMEA; and, since 2013, Asia Chief Actuary.
FANG WANG
EXECUTIVE EDITOR, FORTUNE CHINAFang Wang is Executive Editor, Shanghai, of Fortune China.
Before joining Fortune in March 2021, she spent 18 years at the Financial Times, holding multiple roles including online news editor (New York City), multimedia producer (London), and senior duty editor of the FT’s Chinese website (Beijing).
Fang graduated from New York University in 2003 with an MA degree in business and economic reporting. She received her BA degree in journalism from Fudan University in Shanghai in 1999. Between 1999 and 2001 she was a technology industry reporter at Shanghai Daily.
王黎红
董事长 at 海亮集团有限公司（Hailiang Group）王黎红，女，1968 年出生，绍兴市上虞区人，1998 年 8 月加入中国共产党，正高级经济师，海亮集团党委书记、董事长、总裁。现任中国民营经济研究会副会长、《中国企业报》集团中企党建研究院高级顾问、浙江省女企业家协会常务副会长、省工商联常委、杭州市区域协作发展促进会执行会长、绍兴市文理学院硕士研究生指导教师、绍兴市女企业家协会副会长、诸暨市十八届人大常委会委员、诸暨市九届工商联常务副会长、店口镇十八届党代表。曾任建设银行绍兴分行副行长，民生银行绍兴分行党委书记、行长，绍兴市八届政协委员，绍兴市银行业协会副会长、绍兴市青年企业家协会副会长。曾获中国银行业协会“最佳社会责任管理者奖”，中国民生银行总行“五一劳动奖章”、“优秀共产党员”，“十佳绍兴金融人”，“绍兴市三八红旗手”，绍兴市委组织部“绍兴市担当作为好支书”，绍兴青年企业家协会“二十年突出贡献奖”，“诸暨市经济社会发展和深化改革突出贡献企业（企业经营者）”
，“绍兴市劳动模范”等荣誉称号。
CANDY WENG
CHAIRMAN AND EXECUTIVE DIRECTOR, TANG PALACE (CHIAN) HOLDINGS LIMITEDMs. Weng Peihe has over 30 years experience in the catering industry, is currently the chairman of the Group and an executive director of Tang Palace (China) Holdings Limited, Hong Kong Tang Palace Food & Beverage Group. Ms. Weng is primarily responsible for the Group’s overall corporate operations, planning and business development. She has unique contribution to the Group on the aspects of building and maintaining core management team, establishing corporate culture and actuating lean management.
Ms. Weng was awarded Excellent Female Entrepreneur in China Hospitality Industry by the China Hotel Association in 2004. She was awarded the Platinum Five-Star Medal by the China Hotel Industry Annual Conference in 2010, and was also awarded as Outstanding Female Entrepreneurs in Shanghai Restaurant Industry, jointly by China Hotel Association and Shanghai Restaurant Association in 2011. Ms. Weng was awarded 100 Outstanding Female Entrepreneur by China Outstanding Female Entrepreneur Association in 2012 and 2015. She was selected as the third awardee of the Best Female CEOs of Listed Company by Forbes China in 2018 and was chosen as one of the one hundred “Most Outstanding Women in Commerce in China” by Forbes China in 2019.
ANNE TSE
CEO, PEPSICO GREATER CHINAAnne Tse is fully responsible for company’s business across beverages, snacks and Be & Cheery in Greater China Region, exploring potential new business opportunities, developing talents to achieve greater performance.
Ms. Anne Tse joined PepsiCo in 2010 and has served as senior vice president and general manager of the food business in Greater China. Under her leadership, PepsiCo China began its digital transformation in 2012 and was one of the first food and beverage companies who enter this domain, achieves rapid growth year after year while maintaining its superiority within the industry.
In recent years, the PepsiCo team under the leadership of Anne Tse has achieved recorded phenomenal growth in China in many fields. PepsiCo is consumer-centric and digital-driven, continuously expanding categories, innovating product experiences, improving brand penetration and promoting category growth. The brands have won several awards including "Chinese Favorite Brand" and "Brand with High Growth Potential". At the same time, through close cooperation with channels and retail partners, PepsiCo has also established a leading position in digital business capabilities including global insight, accurate consumer reach and operations, has created many industry precedents and has won the first ranking in the "Advantage Customer Survey" for six consecutive years.
PepsiCo has been actively implementing its sustainable development. In recent years, it has created a number of new rural revitalization and public welfare projects, including "Water Cellars for Mothers", "PepsiCo Nutrition in Action", "Consumption Supports Industrial Revitalization", as well as other sustainable development projects including the use of renewable energy, net zero emissions, water conservation.
Anne is an inspirational leader, she established a local team which has passion, innovation, marketing insights and high performance.
Before joining PepsiCo, Anne was an Associate Partner at McKinsey and Company, and CEO of Mannings China, a subsidiary of Dairy Farm International. She obtained her MBA from Kellogg School of Management, Northwestern University.
YVONNE XIE
NEW MEDIA EXECUTIVE EDITOR, FORTUNE CHINA- WELCOME & SETTING THE AGENDA
- Realizing Your Power
- THE BIG GET TO KNOW YOU
- From 10% to 50%
- Empower People Around you
Yvonne Xie is the new media executive editor of Fortune China. She previously served as the managing editor of the business department for China Daily’s website and as senior manager of global communications for the Dalian Wanda Group. Ms. Xie is the co-winner of the 20th China News Awards for Best Interview. She graduated from Nankai University and the Chinese University of Hong Kong.
PO-LIN HSU
FOUNDER & CEO, MAGASSIST2005-2010 PhD in Electrical Engineering, Cambridge University, UK
2010-2013 PhD in Medical Engineering, RWTH Aachen University, Germany
Board member of ISMCS (International Society of Mechanical Circulatory Support)
2014 Winner of Nose International Fellowship Award from ASAIO (American Society for Artificial Internal Organs)
Professor and doctoral advisor at Soochow University
YING XU
EXECUTIVE CHAIRMAN & CHIEF INVESTMENT OFFICER, VS PARTNERSMs. Xu is Founder，Executive Chairman and Chief Investment Officer of VS Partners (“VSP”).
VSP is a global asset allocator that pioneers the Endowment & Foundation (E&F) institutional approach of global multi-asset allocation, and introduce such capabilities and process into China via Outsourced Chief Investment Officer (“OCIO”) model, a fast-growing asset management model originated from the West. VSP is designed to address the inadequacy in both conventional Western and Chinese domestic asset management, by marrying deep-dive China research and implementation with western institutional investing toolbox organically. It elevates Chinese wealth into the mainstream global institutional ecosystem as long-term respectful and impactful wealth. At the same time, VSP brings China’s best underlying asset strategies and managers to the world markets. With the mission of “Invest for the Betterment of World”, VSP is committed to building people-to-people connections between the East, West and the Rest of the world. Ms. Xu is recognized as one of Fortune China 2022 Most Powerful Women in Business (Ones to Watch).
Prior to founding VSP, Ms. Xu was co-founder and CEO an award-winning Greater China long-only equity fund in the “billion-dollar-club”, managing prominent assets from sovereign-wealth, pension systems, university endowments, prestigious family offices and banking institutions. Prior to that, Ms. Xu was an Investment Officer at Capital International Private Equity Funds (“CIPEF”), a subsidiary of the Capital Group, responsible for CIPEF’s investments in Asia with a particular emphasis on China internet services, consumer, retail and healthcare sectors.
In first decade of the century, Ms. Xu was an investment banker at J.P. Morgan, Credit Suisse and Citigroup, and a management consultant at Monitor Group in Beijing. During those years she acquired extensive experience in corporate strategy, equity & equity-linked structured products, cross border M&A and global capital market regulations.
Ms. Xu received a B.A. of International Economics from Peking University, China, a M.A. of Economics from the Ohio State University, the U.S., and EMBA degree from China Europe International Business School.
YAN HUA
CEO, EVAHEART MEDICAL CO., LTDMrs. Yan, CEO of Evaheart Medical Co., Ltd., responsible for the overall business management and operation, pipeline development and capital operation
Mrs. Yan has been serving in the medical industry for many years. Before joining Evaheart, Mrs. Yan once worked in GE Healthcare, Johnson&Johnson Medical, Boston Scientific, and Allergan, serving as Vice President and General Manager, and responsible for China's overall market strategy, sales and marketing management, business operation, capital investment, mergers and acquisitions, etc.
Before joining the medical industry, Mrs. Yan worked in management consulting industries, providing strategic, mergers and acquisitions, financial consulting, organizational restructuring and other services for customers in high-tech, aviation, energy, consumer goods and other industries.
Mrs. Yan holds master's degree in business administration from Richard Ivey School of Business, University of Western Ontario, Canada, and bachelor's degree in Finance from Sun Yat sen University, Guangzhou, Chinaa. She has worked and lived in more than 10 countries and regions around the world.
VERONIQUE YANG
PARTNER AND SENIOR MANAGING DIRECTOR, CONSUMER PRODUCTS PRACTICE GREATER CHINA HEAD, FASHION & LUXURY PRACTICE AP LEADER, SHANGHAI OFFICE HEAD, BCGMs. Veronique Yang is a Managing Director and Senior Partner of Boston Consulting Group. She is the head of BCG Consumer Products practice in Greater China. She is also the leader of BCG fashion & luxury practice in AP and BCG Shanghai office head.
Veronique has almost 20 years’ experience in consumer goods and retail sectors, providing consulting services to global and local players. Her experience covers various strategy and operational topics, including strategy planning, digital transformation, big data & analytics, market entry, business model innovation, brand positioning and marketing, channel development, e-commerce, organization design, and M&A integration.
Veronique has co-authored many BCG publications, including: The Future of Marketing is Here, Unlocking Growth in CPG with AI and Advanced Analytics, The New China Playbook: Young, Affluent, E-Savvy Consumers Will Fuel Growth, Future of Luxury after COVID, Social Retail playbook in the new era of Digital, Gearing Up for the New Era of China’s Outbound M&A, M&A in China: Getting Deals Done, Making Them Work, and Big Prizes in Small Places: China’s Rapidly Multiplying Pockets of Growth.
Veronique holds an MBA degree from Stanford Graduate School of Business and a BA Degree in Economics from Fudan University.
YANG YANG
MILESTONES OF WINTER SPORTSAs a historical legend of Chinese winter sports, Yang Yang has achieved the Chinese delegation's breakthrough in the gold medal at the Winter Olympics with winning the individual all-around championship of the World Championships six times and is still the only Chinese athlete who has won 59 world class gold medals .
2002 Winter Olympics
The 500m, 1000m Gold Medal
The 3,000 meters relay silver medal
World Championships
Women's Individual All-around champion（6 times）
The 500m, 1000m, 1500m Gold Medal
The 3,000 meters relay gold medal
Retired in 2006, Yang Yang ended his 23-year sports career and has
explored a variety of new identities at all fields. She is actively involved
in sports business and has served as a member of the ISU Committee,
the Olympic Committee, and the chairman of the Athlete Committee
of Beijing Winter Olympics Organizing Committee. Earlier this year,
Yang Yang acted as the Vice president of the New World Anti-Doping
Agency (WADA), protecting the rights and interests of athletes and a
fair environment, while shouldering the responsibility of promoting the
voice of China on international sports platforms.
In addition, Yang Yang was frequently invited to attend a variety of international conferences and public speeches, spreading her ideas to the public and society regarding sports, youth development, and social goods. She is indeed a well-deserved pioneer of Chinese sports culture.
EVA ZHANG
FOUNDER & CEO, INTOCARE MEDICAL TECHNOLOGY (SUZHOU) CO, LTDMrs. Eva Zhang has almost 20 years of experience in R&D and management at some of the world’s top international medical companies. She has worked in the R&D team at GE Healthcare, and later served as R&D Director at Johnson & Johnson’s Asia Pacific R&D Center. With the commitment to establish a Chinese Brand in the global field of cutting-edge medical technology, she founded her own company, IntoCare Medical Technology (Suzhou) Co., Ltd., in 2015.
Focusing on “Transforming Patient Care through Insight and Innovation”, Mrs. Eva Zhang together with her close to 200 innovative and creative employees, are dedicated to taking the lead in improving the quality of healthcare and to benefit more patients via Intelligent and Innovative Medical Technology Solutions.
WEILI ZHANG
MMA WORLD CHAMPIONZhang Weili is a Chinese mixed martial artist. She competes in the strawweight division of the Ultimate Fighting Championship (UFC), where she is the current and two-time UFC Women's Strawweight Champion. She is the first ever Chinese champion in UFC .
When she was 12, her parents sent her to a specialized martial arts school in Handan where she began training in Sanda. After winning Sanda championships of the Hebei province multiple times, a recurring back injury sustained in training forced her to quit the sport early.
At the age of 17 she moved to Beijing, where she worked various odd jobs: cashier at a supermarket, kindergarten teacher, security guard and hotel desk clerk. In 2010 she found a job at a local Beijing gym as a fitness instructor, and was allowed to use their equipment for free after the gym closed in the evenings. She later switched to a front desk job, through which she got to know fighters who trained at the gym. In 2012, She was noticed by coach Cai Xuejun, who recognized her potential and started training her in MMA.
Zhang Weili reclaimed her UFC strawweight champion title in November 2022 at Madison Square Garden in New York after she losing the belt in April 2021.
JIACHEN ZHANG
光之树科技 创始人兼CEO张佳辰，光之树科技创始人&CEO，毕业于哈佛大学肯尼迪政府学院和哈佛商学院，获得公共政策和工商管理硕士学位，并在麻省理工学院人工智能实验室接受联合培养。曾任科创板上市企业九号智能机器人业务COO、亚马逊资深产品经理，领导团队对于前沿科技进行产品化和商业化。现任世界经济论坛数字经济理事会理事、复旦大学泛海金融学院导师，并被《财富》杂志评为2022年中国最具影响力的商界女性之一。
MAIWEN ZHANG
EXECUTIVE EDITOR, FORTUNE CHINAZhang joined FORTUNE China in 2009, and was promoted to Executive Editor in 2013. Zhang currently have more than 2.9 million followers on LinkedIn. Before joining FORTUNE China, Zhang was Managing Editor of InformationWeek China. In 2004, he was admitted by Cambridge, Oxford and Carnegie Mellon University and chose to pursue MSc of Computer Science in Oxford. In 2005, he graduated with straight “A”s from Oxford University, gave up an early offer from a sub company of News Corporation in West London and came back home to continue his career in China’s media business.
Zhang has a BA in English & American Studies from Beijing Foreign Studies University and joined China Daily to work as a reporter and editor. In his earlier days, Zhang won the “best story award” from China Daily twice and played a key role in creating the ELT weeklies for the group. Zhang also got the Certificates of "Building a Business" course from Said Business School, Oxford University, and Finance Media EMBA Fellowship Program from PBC School of Finance, Tsinghua University.
INGRID ZHANG
PRESIDENT, NOVARTIS INNOVATIVE MEDICINES CHINAIngrid Zhang has been President of Novartis Innovative Medicines since June 1, 2022. She oversees the operation and development of Novartis Innovative Medicines across the Chinese mainland and Hong Kong. In this role, Ingrid has been focusing on driving “patient-centric” innovation in the organization and the healthcare industry.
Ingrid was President of Novartis Pharmaceuticals China from 2017 to May 2022. Under her leadership, the company has been accelerating high-quality innovative medicines to China in order to address public health needs, enhancing patients’ access to innovative medicines, and developing an agile and innovative team via culture transformation.
In August 2015, Ingrid was appointed as Country Pharma Organization head & Country President, Poland. During the tenure, she has accumulated valuable experience of leading an international team and achieving significant patient impact.
Prior to joining Novartis in 2011, Ingrid held multiple management roles for multinational pharmaceutical companies like AstraZeneca and Pfizer in different locations, and different disease areas. Ingrid started her career at McKinsey & Company, focusing on healthcare practices.
In addition, Ingrid is the vice chairman of R&D-based Pharmaceutical Association Committee of China Association of Enterprises with Foreign Investment (RDPAC), driving industry initiatives to help achieve the goal of Healthy China.
Ingrid received a master’s degree in chemical engineering from the Pennsylvania State University, and an MBA from the Wharton School of the University of Pennsylvania.
SAMANTHA ZHU
SENIOR MANAGING DIRECTOR & CHAIRPERSON AND MARKET UNIT LEAD FOR GREATER CHINA, ACCENTURESamantha Zhu is Accenture's Chairperson and Market Unit Lead for Greater China. She leads a team of 20,000 professionals that offer Strategy and Consulting, Technology and Operations services and Accenture Song to a wide variety of clients in the region including state-owned entities, private enterprises, and multinationals.
Prior to her current role, Samantha was the Client Group Lead of Communications, Media & Technology for Accenture Greater China. She is responsible for strategic decisions, leading her team to provide professional services to clients in the communications, media and high-tech industries. Before that, Samantha was the Lead of Operations, Accenture Greater China, leading transformational business process outsourcing and information technology infrastructure services, and providing end-to-end intelligent operations solutions for large foreign enterprises, private enterprises and state-owned enterprises to accelerate their digital transformation.
Samantha joined Accenture in 1997 and became a managing director in 2009. During her 20+ years with Accenture, Samantha has been specialized in designing, building and operating large- scale global, regional (APAC) and China transformational outsourcing projects, and delivering management consulting projects including business process re-engineering, ERP system implementation, organization and human performance management and change management for companies in High Tech and manufacturing industries.